|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advanced Life Sciences Inc., of Woodridge, Ill., was awarded U.S. Patent No. 6,399,654 regarding biflavanoids and derivatives thereof as antiviral agents.
Antigenics Inc., of New York, was issued 15 U.S. patents expanding the protection of its heat shock protein technology platform, particularly extending the company's use of HSPs to treat cancers and infectious diseases.
BioMarin Pharmaceutical Inc., of Novato, Calif., was issued U.S. Patent No. 6,426,208 covering Aldurazyme (laronidase) for the treatment of mucopolysaccharidosis I. Aldurazyme is a specific form of purified recombinant human alpha-L-iduronidase that is being investigated as an enzyme ...